June 2019 | Volume 2
MOVING INTELLIGENT CHANGE FORWARD
INNOVATION DIGEST
What is our objective in health care? We talk about having it all - best price, best quality, best access -- but our approaches frequently seem to imply that achieving any one will automatically lead to the others. Not so. We need to focus on the metrics we're trying to attain first, to be able to use it as a benchmark to tell us how we're doing on all three. For example, if we focus intently on driving down price of any service or therapy, will we automatically ensure high quality care and wider access to that care? History and anecdotal evidence from real-world experience gives us the disheartening truth: "not universally." If we focus on widening access to care (even basic, essential, preventive care), will we ensure high quality, reasonable cost? Again, it doesn't play out that way. Why? Time and again, I arrive at the same conclusion. We don't have a sense of health as a common good - one that should be attained by all with a focus on basic, preventive care first. We know (from research and our own experience) that our system tends to favor crisis-focused, end-stage, when-you're-diagnosed care, which is neither the best quality nor the best priced, when you think about it. The healthcare crisis in our country is not one of poor technology, workforce or resources. It's poor articulation of a societal definition of health, poor incentives, poor habits, poor policy and poor leadership. We won't overcome this deficit by denying care until crisis, restricting access to basic preventive services, squabbling about price, or pretending that all in the delivery system aren't acting in their own self-interest first. Those willing to push the conversation about what contributes to "health" and to prioritize programs and policies that help in self-determined progress toward that end should command more of our attention.
Private payers cover more than 40% of drug costs
Estimates on the cost of prescription drugs vary, due in part to inconsistency in calculation methods. Players across the healthcare spectrum, however, agree the cost of prescription drugs is unsustainably high, and the subject has been in the regulatory spotlight for some time now.
Is Our Health Care Spending Worth It?
Many people know by now that the United States spends much more on health care than any other country, and that health outcomes are not a lot better (and in many instances worse). That raises the question: Is our health care spending actually worth it?
JLABS executive on the ROI of a 'no-strings-attached' health tech incubator
When technology entrepreneur Venk Varadan co-founded startup Nanowear five years ago, he had an innovative idea for a cloth-based diagnostic monitoring tool using nanosensor technology. But he faced significant challenges when it came to tackling the nuts and bolts of building the business, such as supply chain, logistics, funding, and healthcare regulations.
Express Scripts to launch digital health formulary for payers, patients
The digital health market continues to grow exponentially with apps that promote fitness, wellness and the prevention of chronic conditions as well as telehealth solutions and remote monitoring tools. But currently, there is no standard way to validate the hundreds of thousands of digital tools available.
NPC, AcademyHealth Offers Tips for Boosting RWD Transparency
The National Pharmaceutical Council (NPC) and AcademyHealth generated potential strategies for boosting transparency and credibility for studies that utilize real-world data (RWD).
Transparency, according to a NPC blog post, remains a key obstacle for more widespread acceptance of studies conducted with RWD.
The Biggest Ways to Reduce Specialty Drug Costs
How can the healthcare industry better curb skyrocketing drug costs? Especially when it comes to specialty pharmacy offerings?
Dan Renick, RPh, MS, president of Precision Value & Health, says this small percentage of the drug market, catering to those with rare diseases or various types of cancers, represent some of the most expensive drugs on the market.
Health Insurer Plans To Optimize Drug Treatment Using Data Analytics
New Jersey’s largest health insurer has partnered with a biopharma vendor to optimize drug treatment using medical and pharmacy claims data. Horizon Healthcare Services will work with vendor Aetion to support case management strategies and develop value-based agreements with pharmas targeting specific patient populations.

Passion + Quality = Change That Matters
  
I embrace the powerful opportunities in our evolving health care landscape. I founded Momentum Health Strategies to be a catalyst for change through continuous learning, diverse engagement and thoughtful policy and practice initiatives. I deliver innovative, strategic thinking and a passion for improving the patient experience. My personal drive and dedication to high-quality results will help you navigate the competitive terrain you face and convert your vision to action.

Momentum Health Strategies

Jennifer L Bright, MPA
(703) 628 - 0534
STAY CONNECTED